Review
Published on 20 Feb 2023
PROTACs: Walking through hematological malignancies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1086946
- 2,969 views
Type at least 3 characters
2,219 articles
Articles
Review
Published on 20 Feb 2023
NF-κB mediated regulation of tumor cell proliferation in hypoxic microenvironment
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1108915
- 2,949 views
- 3 citations
Original Research
Published on 20 Feb 2023
Hydroalcoholic extract of Buxus sempervirens shows antiproliferative effect on melanoma, colorectal carcinoma and prostate cancer cells by affecting the autophagic flow
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1073338
- 1,121 views
Editorial
Published on 20 Feb 2023
Editorial: New immunotherapeutic and pharmacological targets and strategies in haematological malignancies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1161811
- 542 views
Editorial
Published on 20 Feb 2023
Editorial: Targeting tumor EMT-related signaling by natural products
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1152328
- 891 views
Original Research
Published on 17 Feb 2023
Antiangiogenic drugs in combination with seaweed fucoidan: A mechanistic in vitro and in vivo study exploring the VEGF receptor and its downstream signaling molecules in hepatic cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1108992
- 2,656 views
- 5 citations
Case Report
Published on 17 Feb 2023
Chemo-free maintenance therapy in adult T-cell acute lymphoblastic leukemia: A case report and literature review
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1051305
- 1,449 views
Original Research
Published on 16 Feb 2023
Crebanine induces ROS-dependent apoptosis in human hepatocellular carcinoma cells via the AKT/FoxO3a signaling pathway
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1069093
- 2,097 views
- 1 citation
Original Research
Published on 16 Feb 2023
Comprehensive analysis illustrating the role of PANoptosis-related genes in lung cancer based on bioinformatic algorithms and experiments
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1115221
- 5,491 views
- 4 citations
Review
Published on 16 Feb 2023
Therapy resistance in neuroblastoma: Mechanisms and reversal strategies
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1114295
- 3,541 views
- 4 citations
Editorial
Published on 16 Feb 2023
Editorial: New mechanistic insights into cancer precision medicine
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1159703
- 588 views
Review
Published on 16 Feb 2023
Nanoparticle drug delivery systems for synergistic delivery of tumor therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1111991
- 4,275 views
- 8 citations
Review
Published on 15 Feb 2023
Unraveling the significance of exosomal circRNAs in cancer therapeutic resistance
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1093175
- 1,550 views
- 2 citations
Original Research
Published on 15 Feb 2023
Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1113808
- 2,950 views
- 2 citations
Review
Published on 15 Feb 2023
Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1132158
- 3,417 views
- 2 citations
Original Research
Published on 15 Feb 2023
Exploring the mechanism of curcumin in the treatment of colon cancer based on network pharmacology and molecular docking
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1102581
- 7,530 views
- 11 citations